A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy

Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2019

(2019) Stephan Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy

(2018) Amel Karaa et al.   NEUROLOGY

Mitochondrial disease patient motivations and barriers to participate in clinical trials

(2018) Zarazuela Zolkipli-Cunningham et al.   PLoS One

Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome

(2017) Rudolf Schrover et al.   Orphanet Journal of Rare Diseases

Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders

(2015) Shuichi Yatsuga et al.   ANNALS OF NEUROLOGY

Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease

(2015) Gráinne S. Gorman et al.   NEUROMUSCULAR DISORDERS

Mitochondrial reactive oxygen species production and elimination

(2014) Alexander Nickel et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice

(2013) Michael P. Siegel et al.   AGING CELL

Reduction of Early Reperfusion Injury With the Mitochondria-Targeting Peptide Bendavia

(2013) David A. Brown et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

New treatments for mitochondrial disease—no time to drop our standards

(2013) Gerald Pfeffer et al.   Nature Reviews Neurology

Initial development and validation of a mitochondrial disease quality of life scale

(2013) J.L. Elson et al.   NEUROMUSCULAR DISORDERS

Neuro-QOL: Brief measures of health-related quality of life for clinical research in neurology

(2012) D. Cella et al.   NEUROLOGY

Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases

(2012) M. Mancuso et al.   NEUROMUSCULAR DISORDERS

Diagnosis and treatment of mitochondrial myopathies

(2011) Gerald Pfeffer et al.   ANNALS OF MEDICINE

FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study

(2011) Anu Suomalainen et al.   LANCET NEUROLOGY

Exercise Testing in Metabolic Myopathies

(2011) Mark Tarnopolsky   Physical Medicine and Rehabilitation Clinics of North America

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument

(2011) Donald L. Patrick et al.   VALUE IN HEALTH